Authors/Disclosures
|
Michal Lubomski, MBBS
(Royal North Shore Hospital)
|
No disclosure on file |
|
Mary O. Hollist, DO
(Atrium Health)
|
No disclosure on file |
|
Luca Bello
(University of Padova, Department of Neuroscience NPSRR)
|
Mr. Bello has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta Therapeutics. Mr. Bello has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Edgewise Therapeutics. Mr. Bello has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PTC Therapeutics. Mr. Bello has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for PTC Therapeutics. |
|
Romesh Markus, PhD, FRACP, MBChB, FAAN
(St Vincent's Hospital)
|
No disclosure on file |
|
|
No disclosure on file |
|
Stacie L. Demel, DO
(University of Cincinnati Medical Center)
|
Dr. Demel has nothing to disclose. |